OKYO Pharma Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | +217.4% | +0.0% | -86.7% | +0.0% | +625.5% | -57.0% | -57.6% | +6,424.5% | -96.5% | +1,484.7% | -68.1% | +863.2% | -91.7% | +1,935.1% | -94.6% | +111.4% | -35.9% | +37.8% | +18.5% | +100.0% | -47.6% | +0.4% | -18.8% | +100.0% | -83.3% | +126.8% | +45.8% | -30.6% | +0.0% | -31.3% | +5.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6,624.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | -61.7% | +0.0% | +1,232.6% | +0.0% | -83.8% | +198,013.0% | -100.0% | +193,481.2% | -100.0% | +204,320.5% | -99.9% | +269,587.3% | -99.9% | +277,452.2% | -99.9% | +386,600.5% | -99.9% | +242,809.8% | -99.9% | +100.0% | -38.8% | +199,899.6% | -100.0% | +100.0% | -69.6% | +200,069.2% | -100.0% | +199,853.1% | +0.0% | +14.8% | +4,106.8% | |
| – | -39.7% | +0.0% | -45.2% | +0.0% | +4.8% | +0.0% | +0.0% | +0.0% | +151,303.2% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +1,817.1% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.6% | +0.0% | -64.0% | +0.0% | +20,160.2% | +0.0% | -96.9% | +0.0% | -63.6% | +0.0% | +1,187.2% | +0.0% | -87.6% | +639,160.0% | -100.0% | +502,607.8% | -100.0% | +6,107,041.3% | -100.0% | +3,790,639.7% | -100.0% | +1,595,563.1% | -100.0% | +1,632,572.0% | -100.0% | +517,846.8% | -100.0% | +100.0% | -38.8% | +378,421.6% | -100.0% | +100.0% | -69.6% | +271,587.8% | -100.0% | +21,786,803.0% | +0.0% | -33.2% | +129.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,808,744.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -250,550.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +175.9% | -65.9% | +376.0% | -79.0% | +200.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | -4.4% | -29.4% | +322.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,246,949.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -189,182.8% | – | – | – | |
| – | – | +0.0% | -101.5% | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -256,530.0% | – | +286,933.3% | -88.9% | -269,672.5% | – | -277,659.9% | – | -530,882.7% | – | – | – | -300.0% | – | +199,875.9% | -100.0% | +100.0% | -1,272.0% | – | – | -260,826.3% | – | – | +15,159.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -830,132.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -103.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,611,044.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.